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ABSTRACT 
 
A critical function for blood vessels is that they secrete paracrine factors necessary for 
development, homeostasis and repair of the rest of all organs. Among them, the liver is a 
highly vascular organ, and can undergo regeneration after injury. This liver regeneration 
process is governed by dynamic interplay between hepatocytes and non-parenchymal 
cells, liver sinusoidal endothelial cells (LSECs). However, how factors produced from 
LSECs triggered by injury remains to be defined. Following mouse in vivo liver injury 
model, activated platelets deploy stromal cell-derived factor 1 and vascular endothelial 
growth factor A to stimulate CXCR7+ LSECs, orchestrating hepatic regeneration. Upon 
injection of carbon tetrachloride, platelets and CD11b+VEGFR1+ myeloid cells were 
recruited to LSECs enabling to replenish liver mass. Liver regeneration was impaired in 
thrombopoietin-deficient (Thpo-/-) mice repressing platelet production. This impeded 
regeneration phenotype was recapitulated in mice with either conditional ablation of 
Cxcr7 in LSEC (Cxcr7iΔ/iΔ) or Vegfr1 in myeloid cell (Vegfr1lysM/lysM). These mice 
exhibited suppressed expression of hepatocyte growth factor and Wnt2, two crucial 
hepatocyte propagation factors. Administration of recombinant thrombopoietin restored 
the prohibited liver regeneration in the tested genetic models. These results suggest that 
platelets and myeloid cells activate the vascular niche to produce pro-regenerative 
endothelial paracrine factors. Modulating this “hematopoietic-vascular niche” might help 
to develop regenerative therapy strategy for hepatic disorders. 
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Introduction 
 
Hepatic Regeneration for Treatment of End-Stage Liver Diseases 
The liver is vital to life and critical to physiological functions. Traumatic damage of liver 
is frequently hindered with aberrant healing resulting in fibrotic liver formation that lead 
to end-stage liver diseases. Number of deaths in US related to chronic liver disease and 
cirrhosis are ranked as the 8th most common cause of death in adults in the US, that 
36,427 among a total of 2,596,933 deaths were reported in 2013 (Xu, Murphy, Kochanek, 
& Bastian, 2016). Chronic generation of fibrotic tissue is the first stage of liver scarring 
that lead the liver becomes cirrhotic. Cirrhosis is late stage of the fibrotic liver, composed 
most of the liver mass with scar tissue that underlines liver cancer. Liver fibrosis is a 
process of scar formation results from a sustained wound healing process in response to 
chronic liver injuries. The precise mechanism of liver carcinogenesis is unknown, though 
there are known factors that induce chronic liver injuries, including hepatitis B and C, 
obesity-related fatty liver disease, biliary diseases, alcoholic (ASH) and nonalcoholic 
steatohepatitis (NASH), autoimmunity and aflatoxins (Novobrantseva et al., 2005). 
Fibrous scar formation is led by prolonged accumulation of excessive 
extracellular matrix (ECM) proteins, to pronounced distortion of hepatic vascular 
architecture. This process facilitates hepatic endothelial dysfunction and subsequent 
maladaptive hepatocyte regeneration (Friedman, 2000), which ultimately progress 
	 2 
cirrhosis to more serious complications. Portal hypertension is due to increased resistance 
to portal blood flow, spontaneous bacterial peritonitis, and hepatic encephalopathy. Liver 
fibrosis is reversible, whereas cirrhosis is mostly irreversible and results in liver failure or 
the development of hepatocellular carcinoma and death unless liver transplantation is 
performed. (Tsochatzis, Bosch, & Burroughs, 2014). 
Liver transplantation is the major therapy of treatment for patients with the end-
stage liver disease due to hepatitis, genetic disorders and tumor metastasis. Published 
studies have established technologies to allow transplantation of hepatocytes in rodents 
(Benten, Kumaran, et al., 2005; Enami et al., 2009; Joseph et al., 2006; Krohn et al., 
2009; Kumaran, Joseph, Benten, & Gupta, 2005; C. Y. Lee et al., 2003; Wu & Gupta, 
2009; Wu, Joseph, Berishvili, Kumaran, & Gupta, 2008; Wu, Joseph, & Gupta, 2006). 
However, transplantation of liver is hindered by clinical complications and lack of proper 
donor with more than 15,000 patients desperately awaiting liver transplant (Berg et al., 
2009; Bucuvalas et al., 2008; Lonze et al., 2010). The paucity in genetically matched 
donors and hurdles associated with proper liver regeneration have resulted in increased 
morbidity and mortality of many patients, who could have otherwise been treated 
effectively with liver transplantation. 
Hepatocyte transplantation provides for an alternative approach to improve liver 
function. Recently appreciated hepatocyte in the liver in which liver regenerates upon 
injury or partial resection of liver mass (Puppi et al., 2011). Studies have shown that 
intrasplenic transplantation of the liver sinusoidal endothelial cells (LSECs) could repair 
genetic disorders, such as hemophilia in mice (Bandi et al., 2011; Benten, Follenzi, et al., 
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2005; Follenzi et al., 2008). However, expansion of transplanted hepatocytes is 
commonly prohibited by the environment of damaged livers, paradoxically exacerbating 
excessive scarring. Fibrotic scar formation facilitates dysfunction of LSECs, and lead 
maladaptive angiogenesis to form cirrhotic liver. In addition, modulation of oxygenation 
by LSECs has been shown to regulate hepatocyte response to injury (Huebert et al., 2010; 
Iwakiri, Grisham, & Shah, 2008; Kwok, Lee, Culberson, Korneszczuk, & Clemens, 2009; 
J. S. Lee, Semela, Iredale, & Shah, 2007; S. H. Lee, Culberson, Korneszczuk, & 
Clemens, 2008; Semela et al., 2008; Shergill et al., 2010; Yim et al., 2006; Yokoyama et 
al., 2006). Thus, coaxing the surrounding cells such as vascular cells to generate stem 
cell-friendly signals can enhance the growth of transplanted hepatoctyes and can bypass 
scar formation. However, the contribution of LSECs in supporting hepatocyte expansion 
and engraftment for liver regeneration is initiated after mass loss remains enigmatic. 
 
Sinusoidal Endothelial Cells (LSECs) Autonomy and Instruction: Vascular Niche 
Regulates Hepatic Regeneration Status 
In mammals, the liver can undergo regeneration after either chemical injury or surgical 
resection of liver mass, a partial hepatectomy (PH) procedure (Bataller & Brenner, 2005; 
Diehl, 2012; Duffield et al., 2005; Fausto, Campbell, & Riehle, 2006; Friedman, 2008b; 
Hu et al., 2014; Iredale, 2007; Michalopoulos & DeFrances, 1997; Yang et al., 2003; 
Zaret & Grompe, 2008). This regeneration process is governed by dynamic interplay 
between parenchymal hepatocytes and non-parenchymal cells (NPCs) (Duncan et al., 
2010; Fausto et al., 2006; Goessling et al., 2009; Liu et al., 2012; Michalopoulos & 
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DeFrances, 1997; Woo et al., 2012; Zaret & Grompe, 2008), including stellate cells 
(Friedman, 2008b; Yang et al., 2003), LSECs (Apte et al., 2006; Cao, Scandura, et al., 
2016; Ding et al., 2016; Ding et al., 2010; Gracia-Sancho et al., 2007; Huebert et al., 
2010; Iwakiri & Groszmann, 2007; LeCouter et al., 2003; Straub et al., 2008; L. Wang et 
al., 2012), biliary epithelial cells (Malato et al., 2011), and hematopoietic cells (Aspinall 
et al., 2010; Boulter et al., 2012; Duffield et al., 2005; Kodama et al., 2010; W. Y. Lee et 
al., 2010; Lesurtel et al., 2006). Therefore, it will be helpful for designing therapeutic 
interventions for hepatic diseases by defining the multi-cellular interaction orchestrating 
liver regeneration. 
LSECs lining hepatic sinusoidal vasculature are essential in choreographing liver 
organogenesis (Ding et al., 2010; Hu et al., 2014; Matsumoto, Yoshitomi, Rossant, & 
Zaret, 2001; Rafii et al., 2015; Red-Horse, Crawford, Shojaei, & Ferrara, 2007; 
Sakaguchi, Sadler, Crosnier, & Stainier, 2008). During liver development and 
regeneration, LSEC-derived angiocrine factors (Cao et al., 2014; Cao, Lis, et al., 2016; 
Ding et al., 2014; Ding et al., 2010; Ding et al., 2011; Hu et al., 2014; Rafii, Butler, & 
Ding, 2016) regulate synchronized propagation of hepatocyte (Hoehme et al., 2010; Woo 
et al., 2012) and resolve fibrosis (Cao et al., 2014; Cao et al., 2011; Ding et al., 2014). In 
the adult, organ-specific capillary endothelial cells (ECs) support organ regeneration by 
production of angiocrine factors (Avecilla et al., 2004; Butler, Kobayashi, & Rafii, 2010; 
Butler, Nolan, et al., 2010; Hattori et al., 2002b; Heissig et al., 2002; Hooper et al., 2009; 
Kobayashi et al., 2010a; Kopp et al., 2006; Rafii et al., 2003; Rafii, Heissig, & Hattori, 
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2002; Rafii, Mohle, Shapiro, Frey, & Moore, 1997; Rafii et al., 1995; Rafii et al., 1994; 
Seandel et al., 2008) to organ regeneration, such as liver regeneration. 
A critical function for blood vessels is beyond their role in distribution of oxygen 
and nutrients to tissues, is that they secrete paracrine factors which are necessary for 
development, homeostasis and repair of the rest of all organs. Blood vessels support 
organ functions by creating vascular niche that organ specific cell populations wherein 
the blood vessels supply the necessary signals to promote adequate type of factors 
required both to maintain of adequate number of active state of cells required to maintain 
the function of the organ throughout our lifetime, and to support recruitment and 
maintenance of cells to replenish lost cells following injury or normal wear and tear. 
Previously, we have developed models to dissect the role of angiocrine factors 
produced by the LSECs in initiating and sustaining liver regeneration after 70% partial 
hepatectomy  (Ding et al., 2010). Partial hepatectomy (Fausto et al., 2006; Greenbaum et 
al., 1998; J. Jin, Wang, Shi, Darlington, & Timchenko, 2009; Michalopoulos & 
DeFrances, 1997; Timchenko, 2009; H. Wang et al., 2008) and chemical injury models 
(LeCouter et al., 2003) are commonly used to identify the molecular pathways involved 
in hepatic regeneration. However, in chemical-induced hepatic injury models, there is 
structural and functional damage to the vasculature of the liver, rendering the study of 
LSECs in liver regeneration cumbersome (LeCouter et al., 2003). PH model, in which 
there is no perturbation of vascular integrity of the remaining lobes of the liver, provides 
for an ideal model to study angiocrine function of LSECs without causing hypoxia or 
vascular compromise. In the initial 4 days after hepatectomy, refer to as “inductive 
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angiogenesis” (Ding et al., 2010), activation of VEGFR2 followed by upregulation of Id1 
in LSECs induced the expression of angiocrine factors, including hepatocyte growth 
factor (HGF) and Wnt2 (Apte et al., 2009; Apte et al., 2006; Apte et al., 2007; Klein et 
al., 2008; Monga et al., 2003; Ober, Verkade, Field, & Stainier, 2006; Sakaguchi et al., 
2008; Tan et al., 2008). In the adult, hematopoietic cells specifically platelets, are 
enriched within the regenerating lobes of the liver sinusoids and by intravascular 
deposition of vascular endothelial growth factor-A (VEGF-A) (Mohle, Green, Moore, 
Nachman, & Rafii, 1997), and stromal derived factor-1 (SDF-1, CXCL12) (Hamada et 
al., 1998; D. K. Jin et al., 2006; Nachman & Rafii, 2008; Petit, Jin, & Rafii, 2007) from 
platelets (Bertozzi, Hess, & Kahn, 2010; Pang, Weiss, & Poncz, 2005; Zimmerman & 
Weyrich, 2008) activate LSECs to produce angiocrine factors. VEGF-A binds to VEGF 
receptors 1 and 2 on vascular ECs (Carmeliet, 2005; Ferrara, Gerber, & LeCouter, 2003) 
and hematopoietic cells (Fischer, Mazzone, Jonckx, & Carmeliet, 2008; Fong, Zhang, 
Bryce, & Peng, 1999; Grunewald et al., 2006; Kaplan et al., 2005; Stefater et al., 2011) to 
stimulate production of growth factors. Platelets are circulating reservoirs of growth 
factors (Bertozzi et al., 2010; Furrer et al., 2011; D. K. Jin et al., 2006; Lang et al., 2008; 
Lesurtel et al., 2006; Pang et al., 2005; Zimmerman & Weyrich, 2008). In vitro and in 
vivo angiogenic models to identify the phenotype of the organ-specific capillaries (Butler, 
Kobayashi, et al., 2010; Butler, Nolan, et al., 2010; Hooper et al., 2009; Seandel et al., 
2008), found that LSECs compose of specialized liver capillaries that are in direct 
cellular contact with hepatocytes (Ding et al., 2010). 
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In addition to tissue injury triggers platelet activation that leads to VEGF-A and 
SDF-1 secretion to prime LSECs and hematopoietic cells, SDF-1 is demonstrated to 
upregulate its EC-specific cognate receptor CXCR7 to modulate vascular patterning and 
angiocrine factor production (Miao et al., 2007; Sierro et al., 2007; S. Yu, Crawford, 
Tsuchihashi, Behrens, & Srivastava, 2011). Recently, CXCR7 on the LSECs is shown to 
modulate the expression of angiocrine factors that contributed to the initiation and 
maintenance of the liver repair (Ding et al., 2014), enabling a hematopoietic-vascular 
niche orchestrating hepatic regeneration. 
By contract, traumatic hepatic damage model of liver is frequently hindered with 
aberrant healing resulting in fibrotic liver formation. Carbon tetrachloride (CCl4) injury 
model recapitulates the reparative responses occurring in liver diseases after chemical 
injury (LeCouter et al., 2003) via activation of LSECs through production of angriocrine 
factors induced hepatocyte proliferation and liver repair (Ding et al., 2010; Moniaux & 
Faivre, 2011). Within 24 hours post CCl4 injection, but not PH, mobilization of 
inflammatory cells (neutrophils, monocytes, large undifferentiated leukocytes) was 
significantly elevated, but platelet mobilization was significantly elevated more post PH 
than post CCl4 injection (Ding et al., 2010). CCl4-induced liver injury model, in which 
there is significant damage to both hepatocytes and nonparenchymal vascular 
compartment, provides for an ideal model to study angiocrine function of LSECs in 
promoting liver repair. How angiocrine factor from LSECs is triggered by liver injury for 
normal regeneration, as well as the mechanism by which chemical, CCl4 injury induces 
LSECs to produce angiocrine factors that stimulate liver repair remains to be defined. 
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Proposed hypothesis: 
We therefore hypothesized that after hepatectomy hematopoietic cells (specifically 
activated platelets) were recruited to liver sinusoidal vessels and were deploying VEGF-
A and SDF-1, which then stimulated VEGFR2+CXCR7+ LSECs to produce hepatocyte-
active angiocrine factors to initiate and maintain liver regeneration. 
 
Defining the mechanism by which activation of LSECs support liver regeneration will 
open up new therapeutic avenues of research to stimulate hepatocyte regeneration in 
clinical setting. We proposed to use CCl4-induced traumatic hepatic damage model and 
compared with PH-induced compensatory regeneration, demonstrating that activated 
platelets deploy SDF-1 and VEGF-A to stimulate CXCR7+ LSEC and VEGFR1+ myeloid 
cells, support liver regeneration. Three aims were carried out here. 1. Determine 
mechanism by which activation of CXCR7 in VEGFR2+ LSECs are activated to 
paracrine-mediated hepatocyte regeneration. Study with conditional endothelial cell-
specific deletion of CXCR7 and VEGFR2 in the adult mice define the mechanism by 
which SDF-1 and VEGF-A through Id1-dependent induction of angiocrine factors in 
LSECs orchestrate hepatic regeneration. 2. Define the role of recruited hematopoietic 
cells, specifically platelets, in mediating LSEC activation thereby initiating and 
sustaining liver regeneration. After hepatectomy, hematopoietic cells comprising of 
platelets are recruited to LSECs. We hypothesized that platelets by releasing VEGF-A 
and SDF1, turn on Akt-Id1 pathway in VEGFR2+CXCR7+ LSECs to produce angiocrine 
factors initiating liver regeneration. Knock down of VEGF-A and SDF-1 in 
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hematopoietic cells, as well as platelets, define the role of factors in activating LSECs 
and liver regeneration. 3. Determine the role of reciprocal interaction between platelets 
and Akt-activated LSECs in angiocrine factor induction and accelerating hepatocyte 
proliferation.  We hypothesized that after hepatectomy the rapid increase in the volume 
and number of VEGF-A and SDF-1 loaded platelets within liver sinusoidal circulation 
stimulates LSECs. In turn, Akt-activated LSECs facilitate further deposition and 
activation of CD41+SDF1+VEGF-A+ platelets, reinforcing angiocrine factor production. 
Genetic model to selectively activate Akt in LSECs allows us to determine whether 
transplantation of Akt-activated LSECs increases platelet deposition and liver 
regeneration. The role of plasma elevation of SDF-1 and VEGF-A to activate LSECs for 
augmenting hepatocyte proliferation will be assessed. 
This study will pave the way for identification of factors that support long-term 
hepatocyte proliferation in vitro as well as engraftment and regeneration in vivo. This 
finding will set the stage for development of pre-clinical strategies in which by proper 
activation of LSECs or intrasplenic transplantation of LSECs, will allow for initiating and 
maintaining liver regeneration as well as enhancing hepatocyte engraftment.  
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Materials and Methods 
 
Mouse genetic model 
C57BL/6J, LysM-Cre and Rosa-CreERT2 (expressing tamoxifen-responsive inducible Cre) 
mice were obtained from Jackson laboratory. The Chd5(PAC)CreERT2 mice expressing 
tamoxifen-responsive CreERT2 driven by EC-specific VE-cadherin promoter (Ramasamy, 
Kusumbe, Wang, & Adams, 2014; Y. Wang et al., 2010) were provided by Dr. Ralf 
Adams. Thrombopoietin deficient (Thpo-/-) mice (Gurney & de Sauvage, 1996) were 
kindly offered by Dr. Frederic J. de Sauvage (Genentech, Inc., So. San Francisco, CA, 
USA). Mice harboring loxP sites-flanked exon 3 of Cxcr7 (Cxcr7LoxP/LoxP) were kindly 
provided by ChemoCentryx, Inc. (Mountain View, CA, USA). Rosa-CreERT2 animals 
expressing tamoxifen-responsive inducible Cre were described previously (Ding et al., 
2011; D. K. Jin et al., 2006). The Chd5(PAC)CreERT2 mouse line was crossed with floxed 
Cxcr7 mice to generate Cxcr7iΔEC/iΔEC mice and control Cxcr7iΔEC/+ mice after treatment 
of tamoxifen at a dose of 250 mg/kg for 6 days, and interrupted for 3 days after the third 
dose. Mice were rested for at least 20 days after the last injection. Cxcr7LoxP/LoxP mice 
were also crossed with Rosa-CreERT2 mice to generate Cre+Cxcr7loxP/loxP mice, resulting 
Cxcr7 deletion in adult mice (Cxcr7iΔ/iΔ). Floxed Vegfr1 mice (Vegfr1loxP/loxP) were kindly 
provided by Dr. Guo-Hua Fong (Fong et al., 1999), and were crossed with LysM-driven 
Cre (Jackson, Bar Harbor, ME, USA) to generate mice lacking Vegfr1 specifically in 
myeloid cells (Vegfr1lysM/lysM). For all tamoxifen treated mice, mice were allowed to rest 
for at least 20 days after the last injection. Deletion of target genes in ECs was 
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corroborated by quantitative PCR. Six- to eight-week-old male WT mice were used for 
mouse hepatectomy and liver injury models. Sex/age/weight matched mice harboring 
EC-specific gene heterozygous deficiency (geneiΔEC/+) were used as control group for all 
tamoxifen-inducible gene deletion lines. Investigators who performed mouse experiments 
and who analyzed the pattern and extent of cell distribution were randomly assigned with 
animals or samples, and they were blinded to the genotype of the animals or samples 
from different experimental groups. All animal experiments were carried out following 
the guidelines of Institutional Animal Care and Use Committee at Weill Cornell 
Medicine. 
 
Mouse liver regeneration model 
Mouse 70% partial hepatectomy (PH) model was used to induce liver regeneration 
described previously (Ding et al., 2010). Six- to ten-week-old mice were utilized and 
compared. Midline laparotomy was performed in anaesthetized mice, and three most 
anterior lobes (right medial, left medial and left lateral lobes) were resected.  In brief, 
mice were anaesthetized by 100 mg kg-1 intraperitoneal ketamine and 10 mg kg−1 
xylazine. Midline laparotomy was performed in the anaesthetized mice, and three most 
anterior lobes (right medial, left medial and left lateral lobes) containing 70% of the liver 
weight were surgically removed. After opening the upper abdomen and the exposure of 
the liver, the left lobe to be removed was lifted. A 5-0 silk suture tie (Roboz Surgical 
Instrument, Gaithersburg, MD, USA) was placed under the lobe and positioned to the 
origin of the lobe. After three knots were tied, the tied lobe distal to the suture was 
	 12 
resected by a microdissecting scissor. This surgical procedure was then repeated for the 
other median lobes to complete PH procedure. Following surgical removal of 70% of 
liver mass, the peritoneum was re-approximated, and the skin was closed. Sham-operated 
mice underwent laparotomy without lobe resection. Regeneration of liver mass and 
function was assessed by measuring the weight of residual liver lobes and normalizing to 
mouse body weight, as well as serum bilirubin level (Sanofi Genzyme Diagnostics, 
Cambridge, MA, USA) at indicated time points post PH. Regeneration of liver mass and 
functional recovery of liver at indicated time points post PH was assessed by 1) 
measuring the weight of residual liver lobes and normalizing to mouse body weight, 2) 
hepatocyte proliferation by immunostating of Ki67, 3) plasma bilirubin level (Genzyme 
Diagnostics), and aspartate transaminase (AST) and alanine aminotransferase (ALT) 
measurement at indicated time points post PH (Genzyme and Lilai Biology, Chengdu, 
China). 
 
Transplantation of parenchymal cells 
Hepatocyte were purified as previously described via a two-step perfusion and digestion 
procedure (Ding et al., 2010; Wei et al., 2013). 2.5 million isolated hepatocytes were 
transplanted to injured mouse liver via intrasplenic injection (Ding et al., 2010) three 
days after 3rd or 8th injection of CCl4. Intrasplenic injection was also performed as 
previously described. Mice were also sacrificed ten days after injection to assess the 
extent of hepatocyte incorporation in the injured liver. 
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Liver injury models 
To induce liver injury, single injection of carbon tetrachloride (CCl4, Sigma-Aldrich, St. 
Louis, MO, USA) was injected to mice to induce acute liver injury(Ding et al., 2014),(C. 
Yu et al., 2003). Injections of CCl4 were used to induce acute and chronic liver injuries as 
previously described (Ding et al., 2014). In brief, CCl4 was diluted in oil to yield a 
concentration of 40% (0.64 mg ml−1) and injected to mice at a dose of 1.6 mg kg-1. 
 
Measurement of fibrosis 
Liver fibrotic responses were determined at the indicated time points after injection of 
CCl4. Collagen distribution was assessed by Sirius red staining. Hydroxyproline level 
was quantified in the liver to determine the extent of fibrosis (Yoshiji et al., 2000). Liver 
lobes were weighed, homogenized in lysis buffer, and baked in 12 N hydrochloric acid at 
120οC. Samples were aliquoted and added to 1.4% chloramine T in 0.5 M sodium 
acetate/10% isopropanol (Sigma). After incubation for 20 minutes at room temperature, 
the samples were incubated with Erlich’s solution at 65οC for 15 minutes. Absorbance at 
the wavelength of 540 nm was determined, and the content of hydroxyproline was 
calculated by comparing the absorbance to a hydroxyproline standard curve. 
Hydroxyproline level in the tissue was determined based on the weight. PFA-fixed tissue 
sections were stained with Sirius Red to assess collagen deposition and distribution, 
following the protocol of Histoserv (Germantown, MD) or Lilai Biology (Chengdu, 
China). Sirius red-positive fibrotic parenchyma was assessed using five random fields in 
each section23. 
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Human liver fibrosis samples  
Human liver fibrosis (Cat. No. CS516416; CS520446; CS502727; CS504978; 
CS504492) and normal tissues were purchased from Origene (Rockville, MD). Normal 
liver tissues exhibiting regular architecture and morphology were analyzed and compared 
with patient samples. 
 
Isolation and cultivation of LSECs 
Mouse LSECs were isolated by previously described two-step collagenase perfusion 
technique with modifications (Ding et al., 2010). In brief, the liver was perfused with 
Liver Perfusion Medium (Invitrogen, CA), and dissociated by Liver Digest Medium 
(Invitrogen, CA). The non-parenchymal cells (NPCs) were fractionated with Percoll® 
(GE Healthcare Bio-Sciences, Pittsburgh, PA, USA) gradient centrifugation with 75% 
stock Percoll solution and 35% stock Percoll solution. LSEC faction was isolated by 
mouse LSEC binding magnetic beads (Miltenyi, Auburn, CA, USA) and Dynabeads® 
Magnetic Beads conjugated with anti-mouse CD31 antibody (MEC13.3, BD 
Biosciences). Expression of Id1, CXCR7, HGF, and Wnt2 mRNA were determined. 
Primary human LSECs were procured from ScienCell Research Laboratories (Catalog 
#5000, Carlsbad, CA, USA). Expression of factor VIII (DACO, Carpinteria, CA, USA) 
was validated by immunostaining. Akt-LSECs were derived from isolated LSECs that 
were transfected with the pCCL. PGK lentiviral vector with mouse constitutively active 
Akt1 (myristoylated Akt: myrAkt)(Kobayashi et al., 2010a). After starving in serum-free 
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medium, 500,000 LSECs were seeded and stimulated with 10 ng ml-1 SDF-1. LSECs 
were also treated with 30 µM Wortmannin (Sigma-Aldrich). 
 
Stimulation of thrombopoiesis 
To stimulate thrombopoiesis, recombinant TPO, VEGF-A, and/or SDF-1 (PeproTech, 
Rocky Hill, NJ, USA) was injected into Thpo−/− or WT mice i.p. at a dose of 25 µg kg−1 
on a daily basis 10 days before PH or CCL4 injury and afterwards. Vehicle for individual 
cytokines was also injected as a control group. The degree of hepatic regeneration was 
evaluated with control group, including alteration in circulating platelets and parameters 
of hepatogenesis. 
 
Immunostaining and morphometric analysis of tissue cryosections 
Tissues were harvested and cryopreserved as described (Ding et al., 2010; Ding et al., 
2011) for morphometric analysis (Ding et al., 2014; Ding et al., 2010). Mouse liver was 
fixed with 4% paraformaldehyde (PFA) and cryopreserved in optimal cutting temperature 
(OCT) compound. For immunofluorescent (IF) microscopy, the liver sections (10 µm) 
were blocked (5% donkey serum/0.3% Triton X-100) and incubated with anti-VE-
cadherin polyclonal Ab (pAb, 2 µg ml-1, R&D Systems, NE Minneapolis, MN, 
USA), anti-NOX4 pAb (5 µg ml-1, Abcam, Cambridge, MA, USA), anti-desmin pAb (2 
µg ml-1, Abcam). For LSEC identity, anti-VE-cadherin pAb and VEGFR3 (Eli Lilly and 
Co, New York, NY, USA) antibodies was used (Ding et al., 2010; Hattori et al., 2002b; 
D. K. Jin et al., 2006). After incubation in fluorophore-conjugated secondary antibodies 
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(2.5 µg ml-1, Jackson ImmunoResearch, West Grove, PA, USA), sections were 
counterstained with 4,6-diamidino-2-phenylindole (DAPI, Invitrogen, Carlsbad, CA, 
USA). No appreciable staining was observed in isotype IgG controls. Id1 staining was 
performed with rabbit anti-human Id1 antibody (Biocheck, Foster City, CA, USA). To 
reveal platelet activation, antibodies against CD41 and P-selectin (BD Biosciences, San 
Jose, CA, USA) were used, respectively. CD11b (BD Biosciences, San Jose, CA, USA) 
and VEGFR1 antibodies (Eli Lilly and Co.) were used to detect myeloid cells (Ding et 
al., 2010; Hattori et al., 2002a; D. K. Jin et al., 2006). Cell proliferation in vivo was 
measured by 5-Bromo-2’-deoxyuridine (BrdU) uptake. Single dose of BrdU (Sigma, St. 
Louis, MO, USA) at 50 mg kg-1 was i.p. injected to mice 1 h before killing. Liver lobes 
were removed, weighed, and slice of tissues were incubated with 1M HCl at room 
temperature for 1 h, neutralized with 10 mM Tris (pH 8.5) for 15 minutes. After 
incubation with secondary antibody (Jackson ImmunoResearch), cells incorporated with 
BrdU were identified as proliferating hepatocytes. 
 
Image acquisition and analysis 
Histology analysis and Sirius red staining of liver slides were captured with Olympus 
BX51 microscope (Olympus America, Center Valley, PA, USA), and fluorescent images 
were recorded on AxioVert LSM710 (Carl-Zeiss, Thornwood, NY, USA) confocal 
microscope. Co-staining of VE-cadherin with SMA and desmin was also determined. 
Digital images were analyzed using Image J (NIH, Bethesda, MD, USA). Fluorescent 
signals in slide were independently evaluated by two investigators from randomly 
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selected fields of view. Parameters from each individual animal was measured and 
averaged. 
 
Immunofluorescence/Western Blot Analysis 
Samples were immunocytochemically stained as previously described (James et al., 
2010). Briefly, samples were permeabilized in PBST and blocked in 5% donkey serum. 
Samples were incubated for overnight in primary antibodies blocking solution, washed 3 
times in PBS and incubated in CY2- or CY3-conjugated secondary antibodies (Jackson 
Laboratories) for 1 hour. Following washing, some sections were counterstained for 
nucleic acids by DAPI or ToPro3 (Invitrogen) before mounting and imaging by confocal 
microscopy. Primary antibodies used for immunostaining were VE-cadherin (R&D), 
CD31 (BD), and Oct4 (R&D). All imaging was performed using either a Zeiss 510 or 
confocal microscope. Western Blot analysis was performed as previously described 
(Kobayashi et al., 2010b). Antibodies used in these assays: Flag (Sigma-1:1000), VE-
cadherin (Cell Signaling-1:200), VEGFR2 (Cell Signaling-1:2000), pVEGFR2 (Cell 
Signaling-1:300), pMAPK (Cell Signaling-1:2000), GAPDH (Cell Signaling-1:5000), 
and Fli1 (Santa Cruz-1:250). 
 
Flow cytometry analysis 
Flow cytometry was performed on a Becton Dickenson LSRII SORP, flow sorting 
performed on an Aria II SORP. Flow cytometry analysis of platelets and LSECs on 
isolated liver NPCs as previously described (Ding et al., 2010; Hattori et al., 2002b; D. K. 
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Jin et al., 2006). In brief, retrieved livers from killed animals were minced, digested in 
liver digestion medium (Invitrogen), and filtered through a 30-µm strainer. Single-cell 
suspensions were preincubated with Fc block (CD16/CD32; BD Biosciences) and then 
incubated with primary antibodies recognizing mouse LSECs and hematopoietic cells, as 
well as rat IgG2aκ and IgG2aβ isotype control. Antibodies used were directed against 
VEGFR2 (R&D), CD31 (BD), VE-cadherin (eBiosciences), c-kit (BD), EpCam (BD), E-
Cadherin (BD), Tra1-60 (BD), Tra1-81 (BD), CD24 (eBiosciences) and SSEA3 
(BD).  Primary antibodies were directly conjugated to different Alexa Fluor® dyes or 
Quantum Dots using antibody labeling kits (Invitrogen). Labeled cell populations were 
measured by a LSRII flow cytometer (Beckton Dickenson, Franklin Lakes, NJ, USA). 
Compensation for multivariate experiments was carried out with CompBeads (BD 
Pharmingen), gating was performed on fluorophore minus one (FMO) 
controls. Compensation for multivariate experiments was carried out with FACS Diva 
software (Becton Dickinson Immunocytometry Systems). 
 
Gene Expression Analysis by Real-Time Polymerase Chain Reaction 
Total RNA was extracted using RNeasy kit (Qiagen, Germantown, MD, USA). After 
isolation, 500 ng of total RNA was transcribed into complementary DNA by using the 
superscript reverse transcriptase Kit (Invitrogen). The detection of complementary DNA 
expression for the specific genes was performed by using the SYBR® Green quantitative 
polymerase chain reaction (Applied Biosystems, Foster City, CA, USA). To selectively 
knockdown Cxcr7 in LSECs, shRNA lentiviruses were generated by cotransfecting 15 µg 
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of shuttle lentiviral vector, 3 µg of pENV/VSV-G, 5 µg of pRRE, and 2.5 µg of pRSV-
REV in 293T cells (Ding et al., 2014). Viral supernatants were concentrated by 
ultracentrifugation and used to transduce LSECs. Relative quantitative PCR was 
performed on a 7500 Fast Real Time PCR System (Applied Biosystems) using SYBR 
Green PCR mix (Applied Biosystems). Human specific SYBR green primer pairs used 
were: CD31 – f, 5’-tctatgacctcgccctccacaaa–3’, r, 5’ gaacggtgtcttcaggttggtatttca-3’; VE-
cadherin – f, 5’-tggagaagtggcatcagtcaacag-3’, r, 5’-tctacaatcccttgcagtgtgag-3’; VEGFR2 
– f, 5’-actttggaagacagaaccaaattatctc-3’, r, 5’-tgggcaccattccacca-3’; b-Actin – f, 5’-
cgtgcgtgacatcaaagagaa-3’, r, 5’-ggccatctcctgctcgaa-3’; Cycle conditions were: one cycle 
at 50°C for 2 min followed by 1 cycle at 95°C for 10 minutes followed by 40 cycles at 
95°C for 15s and 60°C for 1 minute. Primers were checked for amplification in the linear 
range and primer dissociation and verified. Threshold cycles of primer probes were 
normalized to the housekeeping gene b-Actin and translated to relative values. 
 
Statistical analysis of data  
All data were presented as the mean ± standard error of mean (S.E.M). Comparisons 
between different groups were made using ANOVA. Statistical significance was set 
at P < 0.05. Each experiment was at least 3 times. 
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Results 
 
 
 
Mouse 70% Partial Hepatectomy (PH) Induce Hepatic Regeneration 
The compensatory liver regeneration after surgical resection of liver mass after 70% 
partial hepatectomy (PH) could preserve vascular integrity in the remaining lobes of the 
liver. Therefore, PH provides for an ideal model to study angiocrine function of 
VEGFR3+ LSECs without causing hypoxia or vascular compromise (Ding et al., 2010). 
We have adapted previously developed 70% partial hepatectomy (PH) model (Fausto et 
al., 2006; Greenbaum et al., 1998; J. Jin et al., 2009; Michalopoulos & DeFrances, 1997; 
Timchenko, 2009; H. Wang et al., 2008) and chemical injury models (LeCouter et al., 
2003) to dissect the role of angiocrine factors produced by the LSECs (Figure 1). In PH, 
three most anterior lobes containing 70% of the liver weight were surgically removed. 
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Figure 1: Liver regeneration model - Mouse 70% partial hepatectomy (PH) 
Three most anterior lobes (right medial, left medial and left lateral lobes) containing 
70% of the liver weight were surgically removed. After opening the upper abdomen 
and the exposure of the liver, the left lobe to be removed was lifted. A 5-0 silk suture 
tie was placed under the lobe (green arrows) and positioned to the origin of the lobe. 
After three knots were tied, the tied lobe distal to the suture was resected. B. Sham-
operated mice underwent laparotomy without lobe resection (left). Eight days post 
PH, residual posterior lobes (right lobes and caudate lobes) shows hypertropic 
compensatory regrowth associate with gain of function. Note that the removed lobes 
do not regrow to original shape.  
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Thrombopoiein knockout mice diminished elevated platelet mobilization into 
regenerating liver 
We examined the contribution of CD41+ platelets to compensatory liver regeneration post 
70% PH. Two days post PH, CD41+ platelets harboring VEGF-A and SDF-1 were 
similarly recruited onto VEGFR3+ LSECs (Figure 2A). This indicated a co-localization 
of SDF-1 and VEGF-A with CD41+ platelets on surface of VEGFR3+ LSECs, and was 
enumeration of CD41+ platelets harboring VEGF-A and SDF-1 (Figure 2B). We 
examined mice deficient of thrombopoietin (Thpo-/-) post PH. In Thpo-/- mice, platelet 
number is decreased by ~95% as compared to wild type (WT) mice (Carver-Moore et al., 
1996; Gurney & de Sauvage, 1996). Significant reduction of hepatocyte proliferation in 
regenerating liver, two days post PH was noted in Thpo-/- mice that were compared to WT 
control group (Figure 2C). Hepatic regeneration was markedly decreased in Thpo-/- mice. 
Liver mass restoration eight days post PH were diminished in Thpo-/- mice relative to WT 
group as indicated by caudate and right lobe weight relative to body weight (Figure 2D). 
Together with histology, there is close relationship in the regenerating liver between 
proliferating hepatocytes and VEGFR3+ LSECs, as well as VEGFR3+ LSECs and 
platelets and activation of platelets, and implicate that platelets produce VEGF-A and 
SDF-1 to prime LSECs, eliciting liver regeneration. 
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Figure 2. Post 70% PH, platelets harboring VEGF-A and SDF-1 are associated with 
VEGFR3+ LSECs. 
(A, B) Liver sections were stained with antibodies to CD41 (green), VEGF-A and 
SDF-1 (red) and VEGFR3 (gray). Post PH, but not sham operation (Sham), 
CD41+SDF-1+VEGF-A+ platelets are associated with VEGFR3+ LSECs. Scale 
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bar, 50 µm.  (C, D) BrdU incorporation in hepatocyte (C) and liver mass 
restoration (D) in Thpo-/- and WT mice at day 2 and day 8 post PH, respectively. 
#P < 0.05, compared to control group; N = 5-8 mice per group. 
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Elevated mobilization of platelets into CCl4 injured liver: Similarly to PH liver, we 
examined the contribution of CD41+ platelets after tetrachloride (CCl4)-induced liver 
toxicity on VEGFR3+ LSECs. Platelet activation markers, SDF-1 (Figure 3A) and 
VEGF-A (Figure 3B) were co-stained with platelet surface marker CD41 in the liver 24 
hours after CCl4 i.p. injection. Of note, twenty-four hours post CCl4 i.p. injection at a 
dose of 1.6 mg kg-1, CD41+ platelets harboring SDF-1 and VEGF-A were similarly 
recruited onto VEGFR3+ LSECs. There was structural and functional damage to the 
vasculature of the liver, rendering the study of LSECs in liver regeneration cumbersome. 
Compared to sham mice, CCl4 injection caused significant increase of CD41+ platelets on 
VEGFR3+ LSECs. With the majority of them (~60%) are co-expressing SDF-1 
(CD41+SDF-1+) as well as VEGF-A (CD41+ VEGF-A+) (Figure 3C), indicating 
recruitment of platelet in injured liver, and local activation of platelets secreting SDF-1 
and VEGF-A. 
Parenchymal hepatocytes occupy 70–85% of the liver volume. Whereas non-
parenchymal cells (NPCs) composed of LSECs, cholangiocytes,  Kupffer cells, stellate 
cells, and hematopoietic cells occupy 6.5% of its volume (Kmiec, 2001), which compose 
with 40% of the total number of cells in the liver. Flow cytometric analysis of NPCs 
revealed that unique platelet marker CD41+ cells constituted 24% of NPCs in CCl4-
injured liver but not sham mice (Figure 3D). 73% of CD41+ platelets in the damaged 
liver was co-stained with platelet activation marker, P-selectin. This shows that the CCl4 
injury could recruit platelets on the injured hapatic niche, which might also activate 
platelets. Together with histology, activated platelets promote SDF-1 and VEGF-A, 
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which platelets are recruited on perivascular lumen where LSECs are activated via SDF-1 
and VEGF-A receptors. 
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Figure 3. Hepatotoxic injury recruits CD41+ platelets carrying VEGF-A and SDF-1 to 
liver vasculature. 
(A, B) After intraperitoneal (i.p.) injection of hepatotoxic agent carbon 
tetrachloride (CCl4), CD41+ platelets expressing VEGF-A and SDF-1 were 
recruited to VEGFR3+ liver sinusoidal endothelial cells (LSECs). Liver sections 
were stained with antibodies against platelet-marker CD41, VEGF-A (A), SDF-1 
(B) and LSEC-specific marker VEGFR3. After CCl4 injury, but not administration 
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of PBS (control), CD41+SDF-1+VEGF-A+ platelets were associated with 
VEGFR3+ LSECs; scale bar, 50 µm. (C) Quantification of CD41+SDF-1+VEGF-
A+ platelets associated with VEGFR3+ LSECs. N = 5-7 mice per group. (d) Flow 
cytometry analysis of platelet accumulation in the CCl4-injured and control livers. 
Activation of CD41+ platelets was evidenced by surface expression of activation 
marker P-selectin (CD61). 
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Platelet-deficient mice exhibit impaired liver regeneration after CCl4 injury: To test 
the contribution of platelets in protecting against liver injury, we examined mice deficient 
of TPO (Thpo-/-) after CCl4 injection. Platelet number is decreased in Thpo-/- mice by 
95% as compared to wild type (WT) mice(Carver-Moore et al., 1996; Gurney & de 
Sauvage, 1996). Stimulation of thrombopoiesis in Thpo-/- mice was achieved with i.p.  
injection of recombinant VEGF-A and/or SDF-1 (PeproTech) into Thpo−/− or WT mice at 
daily dose of 25 µg kg−1 for 10 days before CCl4 injury and afterwards. Simultaneously, 
contribution of CD41+ platelets post CCl4 injection, and hepatocyte proliferation was 
enhanced in Thpo-/- mice by injection of VEGF-A and SDF-1 (Figure 4A and B).  
Hepatocyte proliferation after CCl4 injection was significantly reduced in Thpo-/- mice 
than that of WT control group (Figures 4A-C). The impaired hepatocyte proliferation 
was rescued, and enhanced hepatic injury in Thpo-/- mice was significantly rescued 
(Figure 4C). Meanwhile, hepatic injury was markedly increased, as indicated by 
elevation of plasma alanine aminotransferase (ALT) activity (Figure 4D). Of note, the 
impaired hepatocyte proliferation and enhanced hepatic injury in Thpo-/- mice were 
rescued by injection of VEGF-A and/or SDF-1 (Figures 4A-D). Therefore, activated 
platelets recruited to the injured vascular bed supply SDF-1 and VEGF-A to stimulate 
hepatic repair. 
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Figure 4. Platelet-deficient mice exhibit impaired liver regeneration after CCl4 injury. 
(A, B) After CCl4 injury, proliferation (BrdU+) of hepatocytes was prohibited in 
thrombopoietin knockout mice (Thpo-/-) lacking platelets.  
Hepatocyte proliferation was enhanced in Thpo-/- mice by injection of VEGF-A 
and SDF-1. N = 6-8 mice per group. (C) Severe centrilobular damage in the liver 
of Thpo-/- mice after CCl4 injury, as indicated by scattered cell debris in Thpo-/- 
mice relative to mild centrilobular necrosis in WT mice. VEGF-A and SDF-1 
injection ameliorated the injury in Thpo-/- mice. Scale bar, 50 µm. (D) Increased 
hepatic injury (plasma alanine aminotransferase, ALT activity) in Thpo-/- mice 
following CCl4 injection, as compared to WT mice. These data imply that VEGF-
A and SDF-1 produced by activated platelets protect against acute hepatotoxic 
injury. N = 6-8 mice per group. 
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LSECs in regenerating liver up-modulate CXCR7 for compensatory hepatocyte 
proliferation: SDF-1 confers its pro-angiogenic activity (Petit et al., 2007) through 
activation of two receptors, CXCR4 and CXCR7. Of note to CXCR7 expression is 
mainly enriched in vascular endothelial cells (ECs) and subsets of lymphocytes (Gerrits 
et al., 2008; Miao et al., 2007; Sierro et al., 2007; J. Wang et al., 2008). CXCR7 
activation in EC is essential for production of pro-regenerative angiocrine factor in organ 
repair (Cao et al., 2014; Ding et al., 2014). We examined the expression pattern and 
functional attributes of LSEC-specific SDF-1 receptor, CXCR7, post PH (Figure 5A). 
Immunostaining for the expression of CXCR7 on VE-cadherin+ LSECs two days post 
PH, revealed that the CXCR7 was upregulated as it compared to sham-operated mice 
(Figure 5A, B), indicating that CXCR7 might serve as an inducible LSEC-specific SDF-
1 receptor after acute liver resection. 
To test functional contribution of CXCR7 on ECs in regenerating liver of adult 
mice, we employed mice selectively deleted Cxcr7 using an inducible tamoxifen-
responsive CreERT2 that is specifically expressed in ECs (Y. Wang et al., 2010) (Figure 
5C). Mice expressing floxed Cxcr7 were bred with mouse line carrying EC-specific VE-
Cadherin-CreERT2/Cdh5(PAC)CreERT2 (Y. Wang et al., 2010). I.p. injection of tamoxifen 
to resulting offsprings induced 96% of Cxcr7 deletion in ECs of adult mice (Figure 5D). 
These mice lacking Cxcr7 in ECs (Cxcr7iΔEC/iΔEC) were subjected to PH, and liver 
regeneration was compared with control mice harboring endothelial haplodeficiency of 
Cxcr7 (Cxcr7iΔEC/+). Hepatocyte proliferation (Figure 5 E and F) and liver mass 
regeneration (Figure 5G) were markedly reduced in Cxcr7iΔEC/iΔEC mice, as compared to 
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those of control mice. These results strongly suggested that endothelial CXCR7 might be 
essential for promoting liver regeneration post PH. 
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Figure 5. Post 70% PH, SDF-1 receptor CXCR7 is upregulated in LSEC and 
contributes to hepatocyte proliferation. 
(A) Two days after PH, the liver sections were stained for endothelial-specific 
VE-cadherin (green fluorescence). VE-cadherin+ LSECs are co-localized with 
CXCR7+ LSECs (red fluorescence). Scale bar, 50 µm. (b) Cxcr7 mRNA level in 
isolated LSECs was examined at indicated time after PH. The Cxcr7 expression 
level of sham LSEC was arbitrarily defined as 1. N = 5-7 mice per group. (C, D) 
Mice harboring loxP-flanked Cxcr7 were crossed with endothelial cell-specific 
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Cdh5-PAC-CreERT2 mice (Y. Wang et al., 2010). Generated offsprings were 
treated six times with tamoxifen injection (250 mg kg-1) to induce Cxcr7 deletion 
(Cxcr7iΔEC/iΔEC) (Ding et al., 2010). Mice carrying endothelial haplodeficiency of 
Cxcr7 (Cxcr7iΔEC/+) were used as control group. N = 4 mice per group. (E-G) 
Inducible knockout of Cxcr7 in LSEC abrogated hepatocyte proliferation (E, F) 
and restoration of liver mass at indicated time after PH (G). Prohibition of liver 
mass recovery in Cxcr7iΔEC/iΔEC mice persisted for up to 90 days after PH; N = 6-
8 mice per group, P < 0.01 between control and Cxcr7iΔEC/iΔEC group. 
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Compensatory liver regrowth augment induction of CXCR7 on LSEC to Akt-
dependent activation of Id1. Given that CXCR7 is specifically upregulated in LSECs 
after liver injury (Ding et al., 2014), we assessed whether CXCR7 is responsible for 
inducing Id1-dependent production of angiocrine factors for liver repair. This angiocrine 
factrs of LSECs in liver regeneration depends on activation of transcription factor 
inhibitor of DNA binding 1 (Id1) in LSEC (Ding et al., 2010; Rafii et al., 2016). We 
assessed the effect of SDF-1 on cultured human LSECs that are marked with cytoplasmic 
Factor VIII  (Figure 6A). SDF-1 induced both upregulation and nuclear enrichment of 
Id1 protein in LSECs, which was abrogated by genetic silencing of Cxcr7 (Figure 6A 
and B). In addition, SDF-1-dependent Id1 upregulation in LSECs was recapitulated by 
overexpression of Akt, and was suppressed by Wortmannin, an inhibitor of PI3 kinase-
Akt pathway (Figure 6B). These data imply that SDF-1 stimulates CXCR7 in LSECs to 
trigger Akt-dependent activation of Id1 angiocrine pathway. 
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Figure 6. SDF-1 activates CXCR7 on LSEC, inducing Akt-dependent activation of Id1 
angiocrine pathway.  
(A) CXCR7 expression is essential for SDF-1-mediated Id1 nuclear induction. 
Early passages of primary human Factor VIII+ LSECs (hLSECs) were stimulated 
with 10 ng ml-1 of SDF-1. shRNA silencing of CXCR7 in human LSEC abolished 
nuclear accumulation of Id1 after SDF-1 treatment. Note SDF-1 induced 
translocation of Id1 from cytoplasm to nuclei (arrow head). Scale bar, 10 µm. (B) 
PI3 kinase inhibitor Wortmannin blocked SDF-1 mediated upregulation of Id1, 
implicating that SDF-1 induction of Id1 is Akt-dependent. N = 3-5 independent 
experiments. 
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CXCR7 stimulates hepatic regeneration activated via recruited platelets. 
Given that CXCR7 is specifically upregulated in LSECs after liver injury, LSECs 
produce paracrine growth factors such as HGF and Wnt2 that exert regenerative inertia to 
the liver (Ding et al., 2014). We developed inducible deletion of Cxcr7 mice harboring 
loxP-flanked Cxcr7 (Cxcr7LoxP/LoxP) mice. Cxcr7LoxP/LoxP mice were crossed with 
tamoxifen-inducible Rosa-CreERT2 mice to ablate Cxcr7 in adult mice (Figure 7A). 
Generated offspring CreERT2+Cxcr7loxP/loxP mice were treated 6 times with tamoxifen i.p. 
injection (250 mg kg-1), and induced deletion of CXCR7 in adult mice (Cxcr7iΔ/iΔ) 
(Figure 7A). Resulting offspring induced approximately 95% transcriptional level of 
Cxcr7 deletion in the liver of adult mice (Figure 7B). Liver repair was compared 
between Cxcr7iΔ/iΔ mice and WT post CCl4 injection. There were significantly lower 
extent of hepatocytes proliferation in the liver was noted by staining for BrdU 
incorporation for Cxcr7iΔ/iΔ, and higher degree of hepatic injury in Cxcr7iΔ/iΔ mice than 
those of WT mice (Figure 7C and D). Activation of Id1-HGF/Wnt2 angiocrine pathway 
was markedly prohibited in Cxcr7iΔ/iΔ mice, as compared to WT mice (Figure 7E). As 
such, hepatic injury was markedly increased, as indicated by elevation of plasma ALT 
activity, and increased hepatic damage in Cxcr7iΔ/iΔ mice post CCl4 injury was associated 
with abrogated induction of Id1-Wnt2/hepatocyte growth factor (HGF) angiocrine 
pathway. All together, these results suggest that after liver injury, liver recruits platelets 
that supply SDF-1 to activate CXCR7+ LSECs, inducing production of pro-regenerative 
angiocrine factors, Wnt2 and HGF, via Id1 activation for hepatocyte proliferation 
(Figure 7F). 
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Figure 7. After CCl4-induced liver injury, CXCR7 stimulates angiocrine-mediated 
hepatic regeneration. 
 (A) Mice harboring loxP sites-flanked Cxcr7 were crossed with Rosa-CreERT2 
and treated 6 times with tamoxifen injection (250 mg kg-1) to induce deletion of 
Cxcr7 in adult mice (Cxcr7iΔ/iΔ)(Ding et al., 2010). Transcriptional level of Cxcr7 
post CCl4 injury in the liver is shown in B; N = 6-9 mice per group. (C, D) 
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Inhibition of SDF-1 signaling in LSEC abolished liver regeneration after CCl4 
injury. In Cxcr7iΔ/iΔ mice, the decrease in cell proliferation was determined by 
staining for BrdU incorporation; N = 6 mice per group. Scale bar, 50 µm. (E) 
Increased hepatic damage in Cxcr7iΔ/iΔ mice after CCl4 injury was associated with 
abrogated induction of Id1-Wnt2/hepatocyte growth factor (HGF) angiocrine 
pathway; N = 5 mice per group. (F) Platelet-dependent activation of LSECs leads 
to generation of hepatogenic angiocrine factors. Upon hepatotoxic injury, 
activated platelets generate SDF-1 to turn on Id1 pathway in LSECs, resulting in 
angiocrine production of HGF and Wnt2 that initiates hepatocyte propagation 
and liver repair. 
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VEGFR1+ myeloid cells are co-recruited with platelets to vascular niche for 
augmented angiocrine-mediated liver repair 
In the CCl4-injured liver, platelets are recruited and activated. Platelets carry both SDF-1 
and VEGF-A in alpha granules that are readily secreted upon activation. Hence, we 
investigated the contribution VEGF-A receptors in mediating liver repair. VEGF-A was 
shown to accelerate the regeneration post PH liver via activation of VEGFR2 for priming 
LSECs (Ding et al., 2010). VEGFR1 activation mediates early protection post CCl4 liver 
injury (Kato et al., 2011; LeCouter et al., 2003). We, thus, tested the contribution of 
VEGFR1-expressing myeloid cells in the CCl4 injured liver. CCl4 injection caused 
significant recruitment of VEGFR1+ myeloid cells to the regenerating liver. Furthermore, 
these recruited VEGFR1+ myeloid cells co-expressed CD11b and were found close 
proximity to VEGFR3+ LSECs (Figure 8A). To determine the contribution of VEGFR1+ 
myeloid cells to liver repair, Vegfr1loxP/loxP mice (Fong et al., 1999) were crossed with 
LysM-cre mice (Jackson Laboratory) abolishing endogenous Lyz2 gene that is 
specifically expressed in myeloid cells (Figure 8B). Offspring to generate mice lacking 
Vegfr1 (Vegfr1lysM/lysM) resulted to induce 90% transcriptional deletion of Vegfr1 
expression in the liver of adult mice (Figure 8C). Liver damage was substantially 
increased in Vegfr1lysM/lysM, as evidenced by elevated plasma alanine amino transferase 
(ALT) activity (Figure 8D), which liver injury was mitigated by repeated injection of 
recombinant thrombopoietin (TPO) in Vegfr1lysM/lysM mice (Figure 8D). Of note, 
hepatogenic angiocrine Id1 pathway was suppressed in Vegfr1lysM/lysM mice compared to 
control group, which was restored by recombinant TPO injection (Figure 8E). Thus, 
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liver injury recruits platelets and VEGFR1+ myeloid cells to jointly activate LSEC niche, 
driving liver repair (Figure 8F). 
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Figure 8. Activated platelets recruit VEGFR1+ myeloid cells to reinforce angiocrine-
mediated liver repair. 
(A) Recruited VEGFR1+ cells in the liver co-expressed CD11b and were 
associated with VEGFR3+ LSECs, as revealed by immunostaining. Scale bar, 50 
µm. (B, C) Conditional knockout of Vegfr1 in myeloid cells abrogated hepatocyte 
proliferation after CCl4 injection. Floxed Vegfr1 mice were bred with LysM-
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driven Cre to generate mice lacking Vegfr1 in myeloid cells (Vegfr1lyzM/lyzM). 
Quantification of Vegfr1 transcriptional level in myeloid cells is shown in c; N = 
5 mice per group. (D) Exacerbated liver injury in Vegfr1lyzM/lyzM mice than WT 
control, as evidenced by elevated plasma level of alanine aminotransferase, ALT. 
Injection of thrombopoietin (+TPO) prevented liver parenchymal injury in 
Vegfr1lyzM/lyzM mice; N = 5-7 mice per group. (E) Pro-regenerative Id1 angiocrine 
pathway was suppressed in Vegfr1lyzM/lyzM mice, which was elevated by 
thrombopoietin injection (+TPO). Compared to WT control mice, transcriptional 
level of Id1 was lower in Vegfr1lyzM/lyzM mice after CCl4 injury. *P < 0.05, 
compared to Vegfr1lyzM/lyzM group. N = 5-7 mice per group. (F) Schema depicting 
the contribution of hematopoietic-vascular niche for liver regeneration. Upon 
liver injury, activated platelets are recruited to the liver and produce SDF-1 to 
activate CXCR7+ LSECs, initiating endothelial paracrine/angiocrine-mediated 
liver repair. Activation of VEGFR1+ myeloid cells by platelet VEGF-A further 
stimulate Id1-Wnt2/HGF angiocrine pathway in LSEC, reinforcing liver 
regeneration.  
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Discussion 
 
 
LSECs secrete angiocrine factors and actively participate in liver repair. 
Recent recognition for blood vessel function is organ-specific organ homeostasis and 
repair. Inner lining of vessel, endothelial cells (ECs) secrete paracrine factors 
instructively support organ functions by creating vascular niche, and promote adequate 
type of cells in active state to maintain the functional organ throughout our lifetime. 
LSECs lining hepatic sinusoids actively participate in liver repair and regeneration that 
liver can replenish lost cells following toxic traumatic injury or tear loss of liver mass. 
The repair is often hindered with aberrant healing resulting in fibrotic liver formation that 
lead to end-stage liver diseases. Whereas healthy repopulation for lost cells is often 
hindered to loss of liver mass. After removal of the left and median lobes of the liver 
(70% partial hepatectomy) the arterial and portal supply to the remaining lobes of right 
and caudate lobes remain intact. After hepatectomy, by an unknown mechanism, 
VEGFR2 and Id1 pathway are activated in LSECs inducing expression of angiocrine 
factors, such as HGF and Wnt2, that are active to hepatocyte proliferation(Ding et al., 
2010). During the first 4 days of regeneration, Wnt2 and HGF induce hepatocyte 
expansion without LSEC proliferation, (Inductive Angiogenesis). Four days after 
hepatectomy LSECs start to proliferate (Proliferative Angiogenesis), which along with 
hepatocyte propagation, restore liver to its original mass. The initial 4 days after 
hepatectomy is refer to as “inductive angiogenesis” (Ding et al., 2010) via activation of 
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VEGFR2 followed by upregulation of Id1 in LSECs induced the expression of HGF and 
Wnt2 (Apte et al., 2009; Apte et al., 2006; Apte et al., 2007; Klein et al., 2008; Monga et 
al., 2003; Ober et al., 2006; Sakaguchi et al., 2008; Tan et al., 2008). In the mouse liver, 
we have identified a preferential distribution of SDF-1 receptor CXCR7 on LSECs, 
which was upregulated by PH. We have also revealed the functional role of endothelial 
CXCR7 in generating factors that are active to hepatocyte proliferation in both PH and 
CCl4 models. As such, both hepatotoxic injury and loss of liver mass stimulates CXCR7 
activation in LSECs, eliciting hepatic regeneration, and repair. 
 
Bivalent LSEC factors for normal or maladaptive repair 
Surgical resection of liver lobes by partial hepatectomy (PH) triggers facultative 
regeneration without causing fibrosis (Diehl & Chute, 2013; Forbes & Rosenthal, 2014; 
Hu et al., 2014; LeCouter et al., 2003; Matsumoto et al., 2001; Michalopoulos & 
DeFrances, 1997; Wei et al., 2013; Yanger et al., 2014). Similarly, liver can restore 
functional mass and resolve fibrosis after acute injury (Beers & Morrisey, 2011; Islam et 
al., 2012; Jiang et al., 2005; Looney et al., 2009). In contrast, chronic injury stimulates 
exuberant scar formation and fibrosis, leading to liver failure (Bataller & Brenner, 2005; 
Forbes & Rosenthal, 2014; Friedman, 2008a; Friedman, Sheppard, Duffield, & Violette, 
2013; Hecker et al., 2009; Henderson et al., 2013; Jiang et al., 2005; Mehal, Iredale, & 
Friedman, 2011; Noble, Barkauskas, & Jiang, 2012; Pellicoro, Ramachandran, Iredale, & 
Fallowfield, 2014; Seki et al., 2007; Thannickal, Zhou, Gaggar, & Duncan, 2014; Wynn, 
2007; Wynn & Ramalingam, 2012; Zeisberg et al., 2007). How fibrosis is resolved post 
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PH or acute injury but triggered by other types of injury needs to be unraveled 
(Ramachandran & Iredale, 2012). 
Self-repair capacity of liver is sometimes prohibited by overwhelming or 
persistent injury. Transplantation of parenchymal cells might aid in reinstating the 
impaired regenerative ability (Barkauskas et al., 2013; Chapman et al., 2011; Desai, 
Brownfield, & Krasnow, 2014; Duncan et al., 2010; Hogan et al., 2014; Kotton & 
Morrisey, 2014; Kumar et al., 2011; Nishikawa et al., 2015; Ott et al., 2010; Vaughan et 
al., 2015; B. Wang, Zhao, Fish, Logan, & Nusse, 2015; Wangensteen, Zhang, 
Greenbaum, & Kaestner, 2015; Zaret & Grompe, 2008; Zuo et al., 2015). But efficient 
engraftment of parenchymal cells in diseased organ is handicapped by the lack of 
epithelially active niche and existing fibrosis. Upon chronic liver injury (e.g., virus 
infection, alcohol abuse, nonalcoholic steatohepatitis (NASH) and cholestasis) often lead 
to formation of fibrotic liver. The main player is recognized as hepatic non-parenchymal 
myofibroblasts that are key producers of extracellular matrix (ECM) proteins, which 
drives the phenotypic change of parenchymal hepatocytes. Designing efficient cell 
therapy strategy for parenchymal cell engraftment requires understanding of how 
microenvironmental cues promote regeneration and bypass fibrosis in damaged liver 
(Kordes & Haussinger, 2013; Pardo-Saganta et al., 2015; Tata et al., 2013; B. Wang et al., 
2015). Accumulating evidence has suggested a critical role of Cxcr7, in the activation 
process of hepatic myofibroblasts, have all been implicated to regulate LSEC activation 
and hepatocyte apoptosis, both of which are essential steps for initiating liver fibrosis. 
	 47 
Employing the unique phenotypic attributes of LSECs, we have confirmed that 
LSECs leads to elaboration of hepatic-active angiocrine factors via activation of 
transcription factor Id1. Liver regeneration after partial hepatectomy is severely impaired 
in Id1-/- mice, in part because upregulation of angiocrine factors HGF and Wnt2 is 
diminished in Id1-/- mice. Intrasplenic transplantation of LSECs isolated from Id1-/- mice 
that were transduced with HGF and Wnt2 into Id1-/- mice restored the defective liver 
regeneration in Id1-/- mice (Ding et al., 2010). This model provided for an ideal approach 
to interrogate the role of LSECs in liver regeneration as well as to investigate the 
molecular and cellular mechanisms involved in the fibrogenic processes in order to 
design novel therapeutic interventions for liver fibrosis and lays the foundation for 
designing clinical trials to enhance liver regeneration. 
Cultured human and mouse LSECs and demonstrated that LSECs in serum- and 
growth factor-free conditions support expansion of the hepatocytes by production of 
angiocrine factors. We have identified a preferential distribution of SDF-1 receptor 
CXCR7 on LSECs in the mouse liver, which was upregulated by PH. Thus, LSECs 
enable liver stem cell-like hepatocytes to replenish liver cells lost due to PH. Upon 
chemical-induced liver damage, we have revealed the functional role of endothelial 
CXCR7 in unique capacity to support hepatocyte proliferation, and trans-generating 
angiocrine factors that are active in both loss of liver mass by PH and CCl4 hepatotoxic 
injury. Development of fibrosis in damaged organ might hamper engraftment of 
parenchymal cells. Therefore, understanding of how fibrosis is resolved during organ 
regeneration is helpful for devising cellular therapy for various diseases (Thannickal et 
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al., 2014). HGF is implicated to have an important role in promoting parenchymal cell 
expansion (Awuah, Nejak-Bowen, & Monga, 2013; Huh et al., 2004; Matsumoto & 
Nakamura, 1991; Yamamoto et al., 2007). In PH models that normally induce fibrosis-
free parenchymal regeneration, deletion of Cxcr7 in mouse ECs blocked regeneration and 
caused fibrosis. Reciprocally, in mouse liver fibrosis models, ectopic expression of Cxcr7 
in LSECs prevented activation of perivascular fibroblasts and suppressed fibrosis (data 
not shown). These genetic model-based in vivo data implicate that in addition to 
stimulating parenchymal reconstitution, endothelial Cxcr7 serves as a checkpoint 
molecule to prevent fibrosis. 
Following parenchymal injury, Cxcr7 expression might be triggered in vascular 
niche as a protective response. The vast surface area of hepatic microvasculature is ideal 
to supply sufficient amounts of signals within a short period. Several endothelial 
receptors were demonstrated to mediate Cxcr7 upregulation in ECs, including VEGFR1 
(LeCouter et al., 2003), VEGFR2 (LeCouter et al., 2003), and CXCR7 (Zhang et al., 
2015). Conceivably, these endothelial receptors sense tissue mass loss or chemical injury 
to trigger Cxcr7 expression. Loss of these protective pathways might not only impair 
regeneration but also cause fibrosis. It was shown before that activation of Smad2/3 
blocks HGF transcription in keratinocyte (Hoot et al., 2010), suggesting a suppression of 
this checkpoint molecule by TGF/Smad pathway. Whether TGF/Smad pathway mediates 
the loss of checkpoint function in vascular niche during parenchymal repair might be 
explored in the future. 
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Regenerating liver recruit hematopoietic cells to modulate LSEC factors 
Recruited platelets in the injured liver initiates LSEC angiocrine signaling to trigger 
hepatic reconstitution. Post injury, platelets serve as circulating sentinel cells to promote 
tissue repair (Bertozzi et al., 2010; Furrer et al., 2011; Lesurtel et al., 2006; Pang et al., 
2005; Zimmerman & Weyrich, 2008).  Here, our study has implied a paradigm in which 
platelet-supplied SDF-1 activates CXCR7 on LSECs and initiates subsequent angiocrine 
signaling. We found that recruited platelets in the injured liver initiates LSEC angiocrine 
signaling to trigger hepatic reconstitution. Activated platelets deploy SDF-1 and VEGF-A 
to stimulate CXCR7+ LSECs and VEGFR1+ myeloid cell, orchestrating hepatic 
regeneration. This result implied a paradigm in which activated platelets recruited to the 
injured vascular bed supply SDF-1 and VEGF-A to activates CXCR7 on LSECs which 
initiates subsequent angiocrine signaling that instruct healthy hepatic repair. These data 
implicate that platelets produce VEGF-A and SDF-1 to prime LSECs, eliciting liver 
regeneration, which lay the foundation for capitalizing on the instructive functions of 
blood vessels for therapeutic repair from liver failure by efficiently expanding stem cell-
like hepatocyte populations in vitro or in the liver of humans. The beneficial effect of 
platelets in liver repair is in agreement with both preclinical and clinical findings that 
favorable prognosis of hepatic function correlates with higher circulating platelet count 
(Kodama et al., 2010). Whether recombinant thrombopoietin has the similar protective 
effect in infectious liver injury remains to be investigated (Lang et al., 2008). 
The finding that after liver injury, administration of thrombopoietin, SDF-1, 
VEGF-A, enhanced liver repair has clinical relevance. First, it is conceivable that in 
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thrombocytopenic patients, liver repair is impaired. Thus, cautiously increasing the 
number of circulating platelet might offer tissue protection. Alternatively, after acute 
injury, administration of SDF-1 and VEGF-A might augment hepatocyte proliferation by 
stimulating angiocrine factor generation in LSECs. The cytoprotective effect of 
VEGFR1+ myeloid cells after acute injury was evidenced by increased injury in mice 
with myeloid-specific Vegfr1 knockout (Vegfr1lysM/lysM). The rescue effect of 
thrombopoietin injection might depend on both platelets and myeloid cells. The 
diminished Id1 pathway in LSECs of Vegfr1lysM/lysM mice evidenced the effect of 
VEGFR1+ myeloid cells. Conceivably, increasing platelet number by thrombopoietin 
injection enhances platelet-dependent activation of myeloid cells, reinforcing endothelial 
activation and vascular niche-mediated liver regeneration.  
 
Taken together, we demonstrate a pro-regenerative interplay between platelets, myeloid 
cells, and LSEC in liver repair, a unique contribution of vascular and peri-vascular niche 
cells on influencing parenchymal cell repopulation. Platelets play an instrumental role in 
priming both angiocrine function of LSEC and myeloid cells post injury. Thus, platelet 
activation enables a hematopoietic-vascular (Rafii et al., 2015) niche that orchestrates 
liver regeneration. This study further provides insights into active role of blood vessels 
within the vascular niche for liver stem cell-like hepatocytes, which aid in a regenerative 
process. Identifying critical pathways establishing this hepatogenic hematopoietic-
vascular niche might aid in devising regenerative therapy for hepatic diseases. 
Therapeutically, implementing “cell transplantation” with “niche targeting” avenue can 
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potentially induce more efficient organ regeneration than "cell transplantation" alone. 
Transfusion/transplantation of properly primed platelets or myeloid cells can possibly 
offer optimal cell therapy approaches. Our "proof-of-principle" evidence might help to 
develop approaches to enable fibrosis-free repair in various organs. 
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